ATLAS fair value
₩18,202
Above fair value · 98% premium
Oscotec stock price today, ATLAS forecast and fair value
Healthcare · Pharmaceuticals · KOSDAQ · South Korea
Prices as of Oct 26, 2026 · KRW
₩18,202
Above fair value · 98% premium
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Oscotec's fair value at about ₩18,202 per share (reasonable range: ₩10,605 to ₩31,239). At ₩36,000, the stock trades 98% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Oscotec a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩32,206 and ₩39,530; in 9 out of 10, between ₩26,857 and ₩47,404. Estimated annual volatility is 59%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Oscotec sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 039200.KQ has traded between ₩27,300 and ₩66,000. Today it is 45.5% below that high and 32% above its low.
Its beta is 0.77: it tends to move less than the market.
Oscotec Inc. operates as a clinical stage drug discovery and development company.
Want to see everything about Oscotec?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About ₩18,202 per share according to ATLAS (reasonable range: ₩10,605 to ₩31,239). With the stock at ₩36,000, it is 98% above it.
48%: close to a coin flip. In half of the simulated outcomes, 039200.KQ ends the month between ₩32,206 and ₩39,530.
Oscotec's market capitalization is ₩1.3T. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 59%. In a typical month, half of the outcomes end between ₩32,206 and ₩39,530.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy